1. Introduction
1.1. Market Scope and Segmental Definition
1.2. Assumptions & Limitation
2. Research Methodology
2.1. Research Approach & Data Sources
2.2. Forecasting Model
3. Executive Summary
3.1. Analyst's Insights
3.2. Top Line Market estimation
3.3. Value Chain Analysis
4. Market Forces
4.1. Key Industry Drivers, Restraints and Opportunities
4.2. Industry Trends
5. Market Outlook by Device Type (Current size & future market estimates)
5.1. Cardiovascular Diseases
5.2. Oncological Diseases
5.3. Neurological Diseases
5.4. Orthopedic Diseases
5.5. Infectious Diseases
5.6. Other Diseases
6. Market Outlook by Application (Current size & future market estimates)
6.1. Drug Delivery
6.2. Biomaterials
6.3. Active Implants
6.4. Diagnostic Imaging
6.5. Tissue Regeneration
6.6. Other
7. Market Outlook by Regions (Current size & future market estimates)
7.1. North America
7.1.1. U.S.
7.1.2. Canada
7.1.3. Mexico
7.2. Europe
7.2.1. Germany
7.2.2. UK
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Rest Of Europe
7.3. Asia-Pacific
7.3.1. China
7.3.2. India
7.3.3. Japan
7.3.4. Australia
7.3.5. South Korea
7.3.6. Rest Of Asia-Pacific
7.4. Middle East & Africa
7.4.1. GCC
7.4.2. South Africa
7.4.3. Rest of Middle East & Africa
7.5. South America
7.5.1. Brazil
7.5.2. Argentina
7.5.3. Rest of South America
8. Competitive Landscape
8.1. Market Share/Market Ranking Analysis
8.2. Competitive Market Scenario (New Product Innovations, Key Strategic Moves & Partnerships, Start-ups Ecosystem)
9. Company Profiles Includes: Company Overview, Product & Services Offerings, Financials (only for listed companies), New Developments and Innovation)
9.1. Sanofi SA
9.2. Celegene Corporation
9.3. CytImmune Sciences Inc.
9.4. Johnson & Johnson
9.5. Luminex Corporation
9.6. Merck & Co. Inc.
9.7. Nanobiotix
9.8. Pfizer Inc.
9.9. Starpharma Holdings Limited
9.10. Taiwan Liposome Company Ltd